ImageneBio (IMA) EBIT Margin (2020 - 2026)
ImageneBio's EBIT Margin was -749.38% in Q1 2025.
Powered by 
Analysis
ImageneBio (IMA) EBIT Margin (2020 - 2026) Analysis & Trends
For FY2023, EBIT Margin at ImageneBio came in at -823.33%, down 369.34 percentage points from FY2022.
- EBIT Margin shows a three-year change of -339.11 percentage points (FY2020 to FY2023).
- In earlier years, EBIT Margin was -453.99% in FY2022 (-343.81 pp), -110.18% in FY2021 (+374.04 pp) and -484.22% in FY2020.
- The Q1 2025 figure marks the lowest quarterly EBIT Margin since Q4 2023.
- Compared with a year earlier, EBIT Margin was higher in two of the last four quarters, with an average year-over-year change of +433.96 percentage points.
- The best year-over-year quarter for EBIT Margin over five years was Q4 2021 (a gain of 40095.35 percentage points); the worst was Q2 2022 (a drop of 5127.07 percentage points).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 34.46% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 24.35% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 36.01% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 30.74% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 29.12% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 35.79% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 41.71% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 32.98% |
| 10 | ImageneBio | 65.24 Mn | -450.07 Mn | - | -1,455.76% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -1,455.76% |
| Jun 30, 2026 | -944.23% |
| Mar 31, 2026 | -1,069.88% |
| Dec 31, 2025 | -688.79% |
| Mar 31, 2025 | -749.38% |
| Dec 31, 2024 | -93,716.67% |
| Sep 30, 2024 | -58.17% |
| Dec 31, 2023 | -3,324.43% |
| Sep 30, 2023 | -1,645.82% |
| Jun 30, 2023 | -922.65% |
| Mar 31, 2023 | -292.02% |
| Dec 31, 2022 | -277.32% |
| Sep 30, 2022 | -279.23% |
| Jun 30, 2022 | -5,484.55% |
| Mar 31, 2022 | -501.24% |
| Dec 31, 2021 | 13.81% |
| Sep 30, 2021 | -387.67% |
| Jun 30, 2021 | -357.48% |
| Mar 31, 2021 | -279.79% |
| Dec 31, 2020 | -40,081.54% |
API Access
ImageneBio EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=IMA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "IMA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=IMA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();